The EHR company also entered into a partnership to bring behavioral health and deidentified patient data to Holmusk’s real-world clinical database. Holmusk employs artificial intelligence to identify the most pressing behavioral health challenges and research care solutions.
“Mental and behavioral health is a serious global health problem that has only increased during and post the COVID-19 pandemic,” Veradigm CEO Rick Poulton said in a joint Jan. 9 news release. “Holmusk has proven expertise to create the evidence needed to improve mental health. We are proud to equip the company with the resources needed to advance this important work.”
Veradigm led the series B financing round, which also included Novartis venture arm dRx Capital.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
